RATIONALE: Massage therapy may help lessen pain caused by cancer. PURPOSE: This randomized phase II trial is studying how well massage therapy works in treating patients with cancer pain.
OBJECTIVES: * Determine whether the effects of massage therapy in patients with cancer pain are sufficiently promising to warrant a definitive trial. * Determine the feasibility of a definitive trial. OUTLINE: This is a randomized, controlled, pilot study. Patients are stratified according to in-patient status (yes vs no) and first baseline pain score ≥ 7 (yes vs no). Patients are randomized to 1 of 3 treatment arms. * Arm I (massage therapy): Patients receive a light touch ("Reiki") massage over 45 minutes. * Arm II (volunteer visit control): Patients receive a 45-minute visit from a trained volunteer who will be available to sit quietly or talk with the patient to discuss issues of concern, as desired by the patient. Volunteers will not touch the patient except to pat their shoulder or briefly hold their hand. * Arm III (quiet time control): Patients receive 45 minutes of quiet time. Pain and mood are assessed at baseline, immediately after treatment, at 6 hours and 24 hours after treatment, and then daily for the next 5 days after treatment. PROJECTED ACCRUAL: A total of 60 patients will be accrued for this study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
92
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
reduction in pain
A mean change score equivalent to 2 points will be considered the minimum clinically significant reduction in pain
Time frame: 24 hours after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.